Investor profile
Audere Capital
Micro-fund
See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
Audere Capital invests in critical technologies that drive Societal Resilience, including Artificial Intelligence, Robotics and Automation, Advanced Manufacturing, Next Gen Communications, and Cyber Security. The firm focuses on advanced technologies that are increasingly critical in commercial and national priorities, believing that the next era of growth and security will be defined by 'technology inevitabilities'—strategic capabilities essential to future competitiveness, sovereignty, and prosperity. Audere operates at the intersection of policy, strategy, and capital, combining venture investment with strategic advisory and geopolitical intelligence. The fund's GPs have made investments in over 150 technology companies, including 13 unicorns, and leverage a deep network of government, national security, and industry leaders to provide portfolio companies with deal sourcing advantages, policy navigation, procurement access, and connections to institutional customers.
Notable quotes
“Audere Capital is an early-stage venture company focused on investing in five areas of critical technology that are on the cusp of what we think will be a significant multi-decade long run of impact.”
“We invest in early-stage technology companies focused on the intersection of national security and priority, deep tech, and VC.”
“Audere Capital invests in advanced technology solutions that improve societal resilience.”
Team
Dr. Brigham Hyde
Venture Partner
Jennifer Mitrenga
Venture Partner
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| Atropos Health | Strategic / Series A extension | — | 2023-09-21 |
| BioPhy | Seed | $5m | 2023 |
| Second Front Systems | Seed | — | 2022 |
| Latent AI | Seed | — | — |
| Direct Kinetics | Seed | — | — |
| Radical Plastics | Seed | — | — |
| Traxyl | Seed | — | — |
| Heimdall | Seed | — | — |
| Radical Catalyst | Seed | — | — |
| BioPhy (follow-on) | Seed | — | 2025-03-20 |
Frequent co-investors
| VC firm | Deals together |
|---|---|
| Presidio Ventures | 2 |
| Samsung Next | 1 |
| Gaingels | 1 |
| Breyer Capital | 1 |
| Emerson Collective | 1 |
| NEA | 1 |
Fit check
Is Audere Capital a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit